Devises / NAMS
NAMS: NewAmsterdam Pharma Company N.V
22.43
USD
0.93
(3.98%)
Le taux de change de NAMS a changé de -3.98% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 21.55 et à un maximum de 23.59.
Suivez la dynamique NewAmsterdam Pharma Company N.V. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NAMS Nouvelles
- Investing Obicetrapib shows promise in reducing Alzheimer’s biomarkers
- Investing Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating
- Investing NewAmsterdam Pharma updates employment agreement with chief scientific officer
- Investing Thursday’s Insider Moves: Big Buys at NewAmsterdam Pharma, CME Group
- Investing New Amsterdam Pharma director Topper buys shares worth $69k
- Investing Citi initiates coverage on biotech amid improving sentiment in sector
- Investing Citi initiates NewAmsterdam Pharma stock with buy rating on cholesterol drug
- Investing Cantor Fitzgerald maintains NewAmsterdam Pharma stock rating on trial data
- Investing NewAmsterdam Pharma stock maintains buy rating at Stifel on strong data
- Investing Stifel initiates NewAmsterdam stock with Buy rating, $44 target
- Benzinga Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib - NewAmsterdam Pharma Co (NASDAQ:NAMS)
- Investing NewAmsterdam reports Alzheimer’s biomarker reduction
- Investing NewAmsterdam Pharma to Host R&D Day on June 11, 2025
- Investing Cantor Fitzgerald initiates overweight rating for NewAmsterdam Pharma stock
- Investing RBC Capital maintains outperform rating for NewAmsterdam Pharma stock
- Seeking Alpha abrdn Life Sciences Investors Q1 2025 Commentary
- Investing NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
- Investing NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference
- Seeking Alpha abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW)
- Seeking Alpha NewAmsterdam Pharma Stock: Significant Upside Possible Approval Obicetrapib (NASDAQ:NAMS)
- Benzinga Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Agilon Health (NYSE:AGL), Accel Entertainment (NYSE:ACEL)
- Benzinga Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acadian Asset Management (NYSE:AAMI), Accel Entertainment (NYSE:ACEL)
Range quotidien
21.55
23.59
Range Annuel
14.06
27.29
- Clôture Précédente
- 22.78
- Ouverture
- 23.36
- Bid
- 22.43
- Ask
- 22.73
- Plus Bas
- 21.55
- Plus Haut
- 23.59
- Volume
- 3.614 K
- Changement quotidien
- -3.98%
- Changement Mensuel
- 24.54%
- Changement à 6 Mois
- 1.82%
- Changement Annuel
- 32.72%
31 juillet, jeudi
11:30
USD
- Act
- Fcst
- Prev
- 47.999 K
11:30
USD
- Act
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Act
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Act
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Act
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Act
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Act
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Act
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Act
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Act
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Act
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Act
- Fcst
- Prev
- 4.245%
15:30
USD
- Act
- Fcst
- Prev
- 4.265%